Henry Gewurz
#127,945
Most Influential Person Now
Henry Gewurz's AcademicInfluence.com Rankings
Henry Gewurzphilosophy Degrees
Philosophy
#6076
World Rank
#9047
Historical Rank
Ontology
#49
World Rank
#59
Historical Rank
Logic
#3270
World Rank
#4400
Historical Rank
Henry Gewurzbiology Degrees
Biology
#8227
World Rank
#11270
Historical Rank
Immunology
#463
World Rank
#480
Historical Rank
Biochemistry
#1177
World Rank
#1296
Historical Rank
Download Badge
Philosophy Biology
Henry Gewurz's Degrees
- PhD Biochemistry University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
Why Is Henry Gewurz Influential?
(Suggest an Edit or Addition)Henry Gewurz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). (1977) (349)
- Structure and function of the pentraxins. (1995) (324)
- Regulation of complement activation by C-reactive protein. (1999) (323)
- INTERACTIONS OF THE COMPLEMENT SYSTEM WITH ENDOTOXIC LIPOPOLYSACCHARIDE: CONSUMPTION OF EACH OF THE SIX TERMINAL COMPLEMENT COMPONENTS (1968) (272)
- C-reactive protein and the acute-phase response. (1981) (264)
- C-reactive protein is protective against Streptococcus pneumoniae infection in mice (1981) (240)
- Radioimmunoassay of human C-reactive protein and levels in normal sera. (1976) (232)
- INTERACTIONS OF THE COMPLEMENT SYSTEM WITH ENDOTOXIC LIPOPOLYSACCHARIDE (1968) (214)
- Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement. (1975) (204)
- Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. (1983) (198)
- Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q. (1993) (174)
- A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin. (1969) (160)
- Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis. (1976) (158)
- ISOLATION OF AMYLOID P COMPONENT (PROTEIN AP) FROM NORMAL SERUM AS A CALCIUM-DEPENDENT BINDING PROTEIN (1977) (158)
- Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit. (1987) (157)
- Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium. (1983) (153)
- Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma. (1969) (153)
- Effects on C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions (1975) (153)
- Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. (2000) (148)
- Mannose binding lectin (MBL) and HIV. (2005) (147)
- COMPLEMENT AND COMPLEMENT-LIKE ACTIVITY IN LOWER VERTEBRATES AND INVERTEBRATES (1970) (131)
- Complement activity and inflammatory neutrophil exudation in man. Studies in patients with glomerulonephritis, essential hypocomplementemia and agammaglobulinemia. (1967) (127)
- Interactions of alpha1-acid glycoprotein with the immune system. I. Purification and effects upon lymphocyte responsiveness. (1977) (127)
- Inhibition of platelet aggregation by native and desialised alpha-1 acid glycoprotein (1979) (122)
- Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. (2005) (120)
- DNA binds and activates complement via residues 14-26 of the human C1q A chain. (1992) (119)
- Interactions of C-reactive protein with the first component of human complement. (1977) (119)
- The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. (1968) (118)
- Interactions of C-reactive protein with the complement system. II. C- reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations (1975) (115)
- Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. (1991) (113)
- Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis. (1976) (111)
- Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies. (1989) (111)
- A hypocomplementemic vasculitic urticarial syndrome. Report of four new cases and definition of the disease. (1980) (109)
- Complement activation by interaction of polyanions and polycations. (1975) (107)
- Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain (1992) (107)
- The complement system in chronic glomerulonephritis: three newly associated aberrations. (1971) (106)
- Significance of complement to the mechanism of action of endotoxin. (1969) (104)
- Interactions of C-reactive protein with the complement system. III. Complement-dependent passive hemolysis initiated by CRP (1975) (102)
- EFFECT OF COBRA VENOM-INDUCED INHIBITION OF COMPLEMENT ACTIVITY ON ALLOGRAFT AND XENOGRAFT REJECTION REACTIONS1 (1967) (98)
- Potentiation of C1-esterase inhibitor activity by heparin (1976) (97)
- C-reactive protein and the acute phase response. (1981) (91)
- INTERACTIONS OF THE COMPLEMENT SYSTEM WITH THE SURFACE AND ENDOTOXIC LIPOPOLYSACCHARIDE OF VEILLONELLA ALCALESCENS (1967) (87)
- C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b. (1984) (87)
- C-reactive protein and the plasma protein response to tissue injury. (1982) (86)
- Binding reactivity of C-reactive protein for polycations. (1980) (83)
- CHRONIC GLOMERULONEPHRITIS ASSOCIATED WITH LOW SERUM COMPLEMENT ACTIVITY (CHRONIC HYPOCOMPLEMENTEMIC GLOMERULONEPHRITIS) (1970) (83)
- Immunopathologic changes in rheumatoid arthritis synovium (1966) (79)
- C‐REACTIVE PROTEIN REACTIVITY WITH COMPLEMENT AND EFFECTS ON PHAGOCYTOSIS * (1982) (78)
- Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis. (1986) (78)
- Nonimmune activation of the classical complement pathway. (1993) (77)
- ROLE OF THE COMPLEMENT SYSTEM IN GRAFT REJECTIONS IN EXPERIMENTAL ANIMALS AND MAN * (1966) (77)
- Biology of C-reactive protein and the acute phase response. (1982) (77)
- Hereditary deficiency of the third component of complement in a child with fever, skin rash, and arthralgias: response to transfusion of whole blood. (1977) (77)
- Deficiency of C1r in human serum. Effects on the structure and function of macromolecular C1. (1970) (74)
- Effects of C-reactive protein on the lymphoid system. II. Inhibition of mixed lymphocyte reactivity and generation of cytotoxic lymphocytes. (1976) (71)
- Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement. (1969) (69)
- Inhibition of neutrophil activation by alpha1-acid glycoprotein. (1984) (69)
- Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations. (1975) (69)
- Elucidation of a protease-sensitive site involved in the binding of calcium to C-reactive protein. (1989) (68)
- Activation and inhibition of IgG mediated complement fixation by staphylococcal protein A. (1970) (68)
- Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis. (1981) (63)
- Effects of C-reactive protein on platelet function. I. Inhibition of platelet aggregation and release reactions. (1976) (63)
- C1q deficiency associated with urticarial-like lesions and cutaneous vasculitis. (1976) (62)
- Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity (1988) (61)
- Activation of human complement by liposomes: a model for membrane activation of the alternative pathway. (1979) (59)
- Expression of a C-reactive protein neoantigen (neo-CRP) in inflamed rabbit liver and muscle. (1988) (58)
- Anti‐Serum to Cultured Human Lymphoblasts: Preparation, Purification and Immunosuppressive Properties in Man (1969) (55)
- Effects of Hydrocortisone Succinate on the Complement System (1965) (55)
- Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cells. (1991) (54)
- Low molecular weight C1q-precipitins in hypocomplementemic vasculitis-urticaria syndrome: partial purification and characterization as immunoglobulin. (1978) (54)
- Inherited deficiency of the ninth component of complement in man. (1980) (53)
- Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway. (1998) (53)
- Binding of human C-reactive protein to bacteria (1982) (51)
- Interactions of the Complement System with Native and Chemically Modified Endotoxins (1968) (51)
- Interactions of the complement system with endotoxic lipopolysaccharide: the generation of an anaphylatoxin. (1969) (51)
- A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae. (1982) (51)
- Reaction of a Cobra Venom Factor with Guinea Pig Complement and Generation of an Activity Chemotactic for Polymorphonuclear Leukocytes∗ (1969) (50)
- Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniae. (1981) (49)
- C3 nephritic factor and hypocomplementaemia in a clinically healthy individual. (1983) (46)
- Decreased properdin activity in acute glomerulonephritis. (1969) (46)
- Effects of C-reactive protein on lymphocyte functions. III. Inhibition of antigen-induced lymphocyte stimulation and lymphokine production. (1977) (46)
- Complement-dependent biological functions in complement deficiency in man. (1966) (46)
- Serum lipoproteins and C567-INH activity. (1977) (46)
- Deficiency of C7 with systemic lupus erythematosus: solubilization of immune complexes in complement-deficient sera. (1981) (45)
- Binding of C-reactive protein to human lymphocytes. II. Interaction with a subset of cells bearing the Fc receptor. (1981) (45)
- The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection. (1983) (45)
- Complement activation by interaction of polyanions and polycations. III. Complement activation by interaction of multiple polyanious and polycations is the presence of C-reactive protein. (1977) (44)
- Decreased C'-1q protein concentration and agglutinating activity in agammaglobulinaemia syndromes: an inborn error reflected in the complement system. (1968) (44)
- Effects of fraction I from Yersinia pestis on phagocytosis in vitro. (1972) (43)
- Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen. (1976) (42)
- C-reative protein in the rabbit: isolation, characterization and binding affinity to phosphocholine. (1977) (42)
- Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis. (1984) (42)
- Prolongation of renal xenografts by the simultaneous sequestration of preformed antibody, inhibition of complement, coagulation and antibody synthesis. (1971) (42)
- Opsonic properties of C-reactive protein in vivo. (1982) (41)
- Binding reactivity of C-reactive protein for polycations. II. Modulatory effects of calcium and phosphocholine. (1981) (41)
- Activation of platelets by modified C-reactive protein. (1982) (40)
- Interactions of C-reactive protein and complement with liposomes. (1977) (40)
- Possible role for C-reactive protein in the human natural killer cell response (1983) (40)
- Interaction of very low density lipoproteins (VLDL) with rabbit C-reactive protein. (1982) (39)
- Complement in Endotoxin Shock: Effect of Complement Depletion on the Early Hypotensive Phase (1970) (38)
- Complement inactivation by serum from patients with acute and hypocomplementemic chronic glomerulonephritis. (1968) (38)
- Interaction of C-reactive protein with liposomes. III. Membrane requirements for binding. (1981) (38)
- A protease‐sensitive site in the proposed Ca2+‐binding region of human serum amyloid P component and other pentraxins (1992) (38)
- Interactions of C-reactive protein and complement with liposomes. II. Influence of membrane composition. (1979) (38)
- Binding of C-reactive protein to human lymphocytes. I. Requirement for a binding specificity. (1981) (38)
- Effects of anesthesia, surgery and inflammation upon host defense mechanisms. I. Effects upon the complement system. (1975) (36)
- Effect of divalent metal ions and pH upon the binding reactivity of human serum amyloid P component, a C-reactive protein homologue, for zymosan. Preferential reactivity in the presence of copper and acidic pH. (1985) (35)
- INTERACTIONS OF THE COMPLEMENT SYSTEM WITH ENDOTOXIC LIPOPOLYSACCHARIDES IN IMMUNOGLOBULIN-DEFICIENT SERA (1970) (35)
- Aggregated C-reactive protein binds to human polymorphonuclear leukocytes and potentiates Fc receptor-mediated chemiluminescence. (1986) (34)
- l‐Ficolin binding and lectin pathway activation by acetylated low‐density lipoprotein (2007) (34)
- An appraisal of polystyrene-(ELISA) and nitrocellulose-based (ELIFA) enzyme immunoassay systems using monoclonal antibodies reactive toward antigenically distinct forms of human C-reactive protein. (1991) (34)
- Ontogenetic development of the complement system. (1969) (32)
- Purification of cobra venom factor from phospholipase A contaminant. (1976) (32)
- Binding sites for C-reactive protein on human monocytes are distinct from IgG Fc receptors. (1989) (32)
- Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides. (1992) (32)
- Agglutination of complement-coated erythrocytes by serum amyloid P-component. (1981) (31)
- Homozygous C2 deficiency with fulminant lupus erythematosus: severe nephritis via the alternative complement pathway. (1978) (31)
- Interaction of toxic venoms with the complement system. (1971) (31)
- C3 proactivator (C3PA) as an acute phase reactant. (1974) (30)
- Persistent Clq deficiency in a patient with a systemic lupus erythematosus-like syndrome. (1975) (29)
- Detection and analysis of inborn and acquired complement abnormalities. (1982) (29)
- Binding of C-reactive protein to antigen-induced but not mitogen-induced T lymphoblasts. (1976) (29)
- Preferential expression of neo-CRP epitopes on the surface of human peripheral blood lymphocytes. (1988) (29)
- Lysis via the lectin pathway of complement activation: minireview and lectin pathway enhancement of endotoxin-initiated hemolysis. (1999) (28)
- Sub-units of the first complement component in immunologic deficiency syndromes: independence of Cls and Clq. (1970) (27)
- Ontogenetic Development of Clq Synthesis in the Piglet (1970) (27)
- Recurrent bacterial infections associated with C3 nephritic factor and hypocomplementemia. (1983) (27)
- Meningococcal meningitis in a women with inherited deficiency of the ninth component of complement. (1983) (26)
- Effects of C-reactive protein on human lymphocyte responsiveness. (1983) (26)
- Interactions Between Endotoxic Lipopolysaccharides and the Complement System in the Sera of Lower Vertebrates 1 (1970) (26)
- Reactivity of anti-human C-reactive protein (CRP) and serum amyloid P component (SAP) monoclonal antibodies with limulin and pentraxins of other species. (1992) (26)
- Interactions of the complement system with endotoxins from a Salmonella minnesota mutant deficient in O-polysaccharide and heptose. (1968) (25)
- Inhibition of antibody responses to phosphocholine by C-reactive protein. (1984) (25)
- The Immunologic Role of Complement (1967) (25)
- Complement and complement component activities in diseases associated with repeated infections and malignancy. (1968) (24)
- Inherited deficiency of second component of complement and HLA haplotype A10,B18 associated with inflammatory bowel disease. (1978) (24)
- EFFECTS OF C‐REACTIVE PROTEIN (CRP) ON PLATELET FUNCTION * (1982) (24)
- C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP. (1988) (24)
- Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity. (1978) (24)
- Interaction of human immunodeficiency virus (HIV) glycans with lectins of the human immune system. (2006) (22)
- Xenograft rejection by dog and man: isolated kidney perfusion with blood and plasma. (1971) (22)
- Genetic independence between the HL--A system and deficits in the first and sixth components of complement. (2008) (22)
- The development of immunological capacity in phylogenetic perspective. (1967) (21)
- Effects of C-reactive protein on platelet function. III. The role of cAMP, contractile elements, and prostaglandin metabolism in CRP-induced inhibition of platelet aggregation and secretion. (1977) (21)
- Prevention of Experimental Allergic Encephalomyelitis with Cobra Venom Factor 1 (1971) (21)
- Inflammation-induced changes in rabbit CRP and plasma lipoproteins. (1983) (20)
- Evidence that serum amyloid P component binds to mannose-terminated sequences of polysaccharides and glycoproteins. (1988) (20)
- COMPLEMENT FIXATION DURING HOMOGRAFT REJECTION. (1965) (19)
- Immunosuppressive assay of antilymphoblast globulin in man: effect of dose, histocompatibility, and serologic response to horse gamma globulin. (1970) (19)
- Inborn C1r dificiency with a mild lupus-like syndrome. (1979) (19)
- The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity. (1972) (19)
- Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes. (1976) (18)
- Cleaved forms of C-reactive protein are associated with platelet inhibition. (1986) (18)
- Potentiation of C56-initiated lysis by leucocyte cationic proteins, myelin basic proteins and lysine-rich histones. (1976) (17)
- Effect of C-reactive protein on the complement-mediated stimulated of human neutrophils by Streptococcus pneumoniae serotypes 3 and 6 (1982) (17)
- C-reactive protein antigenicity on the surface of human lymphocytes. (1983) (16)
- C567-initiated cytolysis of lymphoid cells: description of the phenomenon and studies on its control by C567 inhibitors. (1977) (16)
- Platelet inhibitory effects of CRP preparations are due to a co-isolating low molecular weight factor. (1982) (16)
- A simple diagnostic test for hereditary angioneurotic edema. (1970) (15)
- Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus. (1984) (15)
- Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action. (1975) (15)
- Antihuman lymphoblast globulin. (1970) (14)
- Effect of C4 depletion on the utilization of the terminal components of guinea-pig complement by endotoxin. (1971) (14)
- Genetic aspects of deficiency of the ninth component of complement in man. (1980) (14)
- IgE myeloma presenting with classical myeloma features. (1976) (14)
- Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system. (1991) (13)
- Modulation of platelet activation by native DNA. (1979) (13)
- Complement sensitivity of neuraminidase-treated lymphoid cells. (1971) (13)
- The Effects of C‐Reactive Protein on Human Cell‐Mediated Cytotoxicity (1986) (13)
- Immunosuppression by antihuman lymphocyte globulin: correlation of human and animal assay systems with clinical results. (1971) (12)
- Component deficiencies. 9. The ninth component. (1986) (11)
- Studies on the inhibition of C56 initiated lysis (reactive lysis). I. Description of the phenomenon and methods of assay. (1974) (10)
- The complement system in hereditary angioneurotic oedema--a new perspective. (1968) (9)
- Selective inhibition of platelet activation by the amyloid P-component of serum. (1983) (9)
- Alternative Modes and Pathways of Complement Activation (1977) (9)
- Activation of human complement by liposomes: serum factor requirement for alternative pathway activation. (1980) (9)
- Preferential binding and aggregation of rabbit C-reactive protein with arginine-rich proteins. (1991) (9)
- Identification of a novel antigenic specificity present on the surface of human natural killer cells and B lymphocytes (1987) (8)
- Decreased C5b67-inhibitor activity in two families with hereditary functional deficiency of the eighth component of complement. (1983) (8)
- Immunological abnormalities in Job's syndrome (1971) (8)
- Studies of the inhibition of C56-initiated lysis (reactive lysis). IV. Antagonism of the inhibitory activity c567-INH by poly-L-lysine. (1975) (8)
- Antiserum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man (1970) (8)
- Reactivities to horse anti-lymphocyte globulin. II. Serum sickness nephritis with complement alterations in man. (1970) (8)
- Inhibition of Rabbit Platelet Aggregation and Clot Retraction by Rabbit and Human C-Reactive Proteins 1 (1977) (8)
- Antibody and complement in the stimulation of neutrophil chemiluminescence by Neisseria meningitidis: studies in a patient with complete deficiency of C7. (1982) (8)
- Enhancement of C56-initiated lysis by cell-bound C3 fragments: evidence for a mechanism independent of the prior binding of C56 to C3b. (1977) (8)
- Studies on the inhibition of C56-initiated lysis (reactive lysis). II. C567-INH--an inhibitor of the C567 trimolecular complex of complement. (1974) (7)
- Lectin pathway hemolysis in the serum of the guinea pig and other species (1998) (7)
- Non-Immune Activation of Complement: Two New Phenomena1, 2 (1973) (7)
- Identification of multiple forms of the P component of amyloid isolated from human serum. (1988) (7)
- Reactivities to Horse Anti-Lymphocyte Globulin (1970) (7)
- Effector mechanisms in renal graft rejection. (1967) (7)
- Significane of intravascular coagulation in canine endotoxin shock (1975) (7)
- The mechanism of increased sensitivity of neuraminidase treated cells to antibody induced cytolysis. Abstr. (1970) (7)
- Binding of the complement intermediate C56 to zymosan in acute phase human sera. (1975) (6)
- Component deficiencies. 7. The seventh component. (1986) (6)
- DEFICIENCY OF C1r IN HUMAN SERUM (1970) (6)
- Comparison of the enzymatic sensitivities of the platelet receptor for human C-reactive protein and its functional relationship to the platelet IgG Fc receptor. (1982) (6)
- Serum complement: An indicator of accelerated homograft rejection in man (1965) (5)
- Forced flow electrophoretic purification of anti-human antilymphoblast globulin. (1970) (5)
- Inhibition of platelet aggregation by a myeloma protein with anti-phosphocholine specificity (1976) (5)
- BIOSYNTHESIS AND POSTSYNTHETIC ASSEMBLY OF HUMAN C REACTIVE PROTEIN (CRP) (1984) (5)
- Complement-dependent hemolysis in human serum via the lectin pathway: Regulation by C4bp, factor H and immunoglobulins (1998) (5)
- Cobra venom factor-induced activation of the complement system: developmental, experimental and clinical considerations. (1971) (5)
- Pretreatment with deaggregated horse gamma-globulin. Failure to enhance tolerance to horse antilymphoblast globulin in man. (1970) (5)
- BINDING REACTIVITIES OF SERUM AMYLOID P‐COMPONENT (1982) (4)
- A new efficient method for preparation of immunoelectrophoretically pure horse antihuman antilymphoblast globulin. (1969) (4)
- Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor. (1975) (4)
- The titration curve of native C reactive protein (1983) (4)
- Complement (Clq), polyanions and platelet activation. (1980) (3)
- Clinical Assay of the Complement System (1977) (3)
- Reactivities to horse anti-lymphocyte globulin. I. Induction of immunologic tolerance in man. (1970) (3)
- Influence of heparin on interactions between C-reactive protein and polycations. (1983) (3)
- A rapid pH Stat assay for plasma prekallikrein and fluctuations in disease. (1974) (3)
- Nonimmune Activation of C: Two New Phenomena (1973) (3)
- Renal transplantation in a patient with hereditary deficiency of the second component of complement. (1981) (3)
- 744 IDENTICAL TWIN GIRLS WITH RECURRENT SEVERE INFECTIONS ASSOCIATED WITH THE ABSENCE OF THE SECOND COMPONENT OF COMPLEMENT (1978) (3)
- Interaction Between Endotoxic Lipopolysaccharides (LPS) and the Complement (C) System: Solubilization of C-Consuming Substances During Brief Absorbtions at 0° 1 (1971) (3)
- Complement Activation by Liposome-CRP Complexes: Influence of Membrane Composition (1978) (2)
- Desensitisation to horse-globulin before immunosuppressive treatment. (1970) (2)
- Induction of tolerance to horse gamma globulin (HoGG) and antilymphocyte globulin (HoALG) in humans and experimental animals. (1971) (2)
- Effects of heparin and alpha 1-acid glycoprotein on thrombin or Activated Thrombofax Reagent-induced platelet aggregation and clot formation. (1983) (2)
- The effect of common antibiotics on lymphocyte transformation (1975) (1)
- Bystander Hemolysis by Complement Activation in the Fluid Phase (1976) (1)
- Modulation of c reactive protein and immunoglobulin g binding to human monocytes by surface immobilized ligands (1986) (1)
- 732 Clr DEFICIENCY: PRESENTATION AS A MILD LUPUS LIKE SYNDROME (1978) (1)
- Characterization of C-reactive protein and the complement subcomponent Clt as homologous proteins displaying cyclic pentameric symmetry (pentraxins) (amino acid sequence/electron microscopy/amyloid P-component/evolution) (2016) (1)
- Induction of immunologic tolerance to antilymphocyte globulin in man. (1969) (1)
- CRP‐LIPOPROTEIN INTERACTION DURING THE ACUTE PHASE RESPONSE IN RABBITS (1982) (1)
- Complement Dependent Adherence, Phagocytosis and Hemolysis Initiated by C-Reactive Protein (CRP) (1976) (1)
- Testing for Complement Defects (1981) (1)
- Evidence for lack of linkage between HLA and C3 deficiency in man (1977) (1)
- C-reactive protein in aging Lobund Wistar rats. (1989) (0)
- Ontogenetic development of C1q synthesis in the piglet. (1970) (0)
- Lipopolysaccharide binding and inhibition of LPS-initiated C activation and microphage cytokine release by plymers of C1Q a chain peptide 14–26. (1993) (0)
- Interactions between CRP and Mononuclear Cells (1982) (0)
- COMMUNICATIONS (1968) (0)
- Interactions between MBL and the MASP proteins in lectin pathway hemolysis (2000) (0)
- Decreased properdin activity in Swiss-type lymphopenic agammaglobulinemia. (1968) (0)
- Ficolin binding and lectin pathway activation by acetylated-LDL (2007) (0)
- Localization of Sites through which C-reactive Protein Binds and Activates Complement to Residues 14-26 and 76-92 of the Human Clq A Chain By H. Jiang,* F. A. Robey,~ and H. Gewurz* (2003) (0)
- Further studies of c-reactive protein protection against pneumococcal infection in mice. Abstr. (1982) (0)
- Roles for C3 and alpha-2 macroglobulin in the transportation and activation of MASP-2 in normal human serum (2007) (0)
- FAMILIAL C4 DEFICIENCY WITH PROLIFERATIVE GLOMERULONEPHRITIS AND ELEVATED SWEAT ELECTROLYTE CONCENTRATIONS (1977) (0)
- Contents, Vol. 34, 1968 (1968) (0)
- Interactions of Human C1̄ with C-Reactive Protein and Polyanion-Polycation Complexes (1976) (0)
- Enhancement of allograft survival by prior exposure to a heterologons antigen system. (1970) (0)
- Interaction of HIV-1 with mannose binding lectin (2000) (0)
- Activation ofplatelets bymodified C-reactive protein (1982) (0)
- Reactivities to horse anti-lymphocyte globulin. 3. The induction of immunologic paralysis of horse gamma-globulin (HoGG) and anti-lymphocyte globulin (HoALG) in adult rabbits. (1971) (0)
- Contents, Vol. 40, 1971 (1971) (0)
- D E F I C I E N C Y of C L R I N H U M a N S E R U M Efi~ects on the Structure and Function of Macromolecular Ci* (1969) (0)
- 50 Hemolytic plate assays (HPA) in the clinical analysis of the complement (C) system (1988) (0)
- Interaction between C-Reactive Protein (CRP) and Platelets (1982) (0)
- [Opsonic effect of CRP on the in vivo clearance of sensitized, autologous erythrocytes]. (1982) (0)
- Contents, Vol. 36, 1969 (1969) (0)
- Synergistic effects of cytosine arabinoside combined with antilymphocyte globulin for suppressing xenograft rejection. (1969) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Henry Gewurz?
Henry Gewurz is affiliated with the following schools:
